NO970519L - Behandling av type II diabetes mellitus med amylinagonister - Google Patents
Behandling av type II diabetes mellitus med amylinagonisterInfo
- Publication number
- NO970519L NO970519L NO970519A NO970519A NO970519L NO 970519 L NO970519 L NO 970519L NO 970519 A NO970519 A NO 970519A NO 970519 A NO970519 A NO 970519A NO 970519 L NO970519 L NO 970519L
- Authority
- NO
- Norway
- Prior art keywords
- diabetes mellitus
- type
- treatment
- amylin agonists
- amylin
- Prior art date
Links
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- 229940127438 Amylin Agonists Drugs 0.000 title 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 abstract 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/483,188 US6143718A (en) | 1995-06-07 | 1995-06-07 | Treatment of Type II diabetes mellutis with amylin agonists |
PCT/US1996/009875 WO1996040220A1 (en) | 1995-06-07 | 1996-06-07 | Treatment of type ii diabetes mellitus with amylin agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970519D0 NO970519D0 (no) | 1997-02-05 |
NO970519L true NO970519L (no) | 1997-04-07 |
Family
ID=23919034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970519A NO970519L (no) | 1995-06-07 | 1997-02-05 | Behandling av type II diabetes mellitus med amylinagonister |
Country Status (19)
Country | Link |
---|---|
US (2) | US6143718A (ru) |
EP (1) | EP0772451B1 (ru) |
JP (1) | JP4009319B2 (ru) |
AT (1) | ATE228849T1 (ru) |
AU (1) | AU721489B2 (ru) |
BG (1) | BG101230A (ru) |
CA (1) | CA2196999C (ru) |
CZ (1) | CZ289043B6 (ru) |
DE (1) | DE69625157T2 (ru) |
DK (1) | DK0772451T3 (ru) |
ES (1) | ES2187659T3 (ru) |
HU (1) | HUP9700368A3 (ru) |
IN (1) | IN181672B (ru) |
NO (1) | NO970519L (ru) |
PT (1) | PT772451E (ru) |
RU (1) | RU2166958C2 (ru) |
SK (1) | SK18697A3 (ru) |
WO (1) | WO1996040220A1 (ru) |
ZA (1) | ZA964838B (ru) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
DE69426304T2 (de) * | 1993-09-07 | 2001-03-15 | Amylin Pharmaceuticals, Inc. | Methoden zur regulation der den magen und darm betreffenden motilitaet |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
US6410511B2 (en) | 1997-01-08 | 2002-06-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
US7312196B2 (en) | 1997-01-08 | 2007-12-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
US7101853B2 (en) * | 1997-05-06 | 2006-09-05 | Amylin Pharmaceuticals, Inc. | Method for treating or preventing gastritis using amylin or amylin agonists |
US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
AU760609B2 (en) * | 1998-01-09 | 2003-05-15 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
US6087334A (en) * | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
NZ534557A (en) * | 2002-01-08 | 2007-10-26 | Amylin Pharmaceuticals Inc | Use of amylin or amylin agonists in the manufacture of a medicament for use in the treatment of dyslipidemia, wherein the medicament reduces post-prandial triglyceride levels |
JP4579681B2 (ja) * | 2002-07-09 | 2010-11-10 | ブリストル−マイヤーズ スクイブ カンパニー | 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法 |
AU2004241242A1 (en) * | 2003-05-14 | 2004-12-02 | Emisphere Technologies, Inc. | Compositions for delivering peptide YY and PYY agonists |
EP1644027B1 (en) * | 2003-07-16 | 2014-04-09 | Evotec International GmbH | Use of pleiotrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
BRPI0507623A (pt) * | 2004-02-11 | 2007-07-03 | Amylin Pharmaceuticals Inc | peptìdeos da famìlia da amilina e métodos para prepará-los e empregá-los |
US20050209148A1 (en) * | 2004-02-20 | 2005-09-22 | Arnon Rosenthal | Methods of treating obesity or diabetes using NT-4/5 |
US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
EP2457564A1 (en) * | 2005-03-11 | 2012-05-30 | Endo Pharmaceuticals Solutions Inc. | Controlled release formulations of octreotide |
US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
WO2007088476A1 (en) * | 2006-02-02 | 2007-08-09 | Rinat Neuroscience Corp. | Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist |
EP1988920A1 (en) * | 2006-02-02 | 2008-11-12 | Rinat Neuroscience Corp. | Methods for treating obesity by administering a trkb antagonist |
EP2114436A1 (en) * | 2006-12-20 | 2009-11-11 | Rinat Neuroscience Corp. | Trkb agonists for treating autoimmune disorders |
AU2007360979B2 (en) * | 2007-11-14 | 2014-04-10 | Amylin Pharmaceuticals, Llc | Methods for treating obesity and obesity related diseases and disorders |
CN102231976B (zh) | 2008-06-25 | 2014-05-07 | Endo药物方法有限公司 | 具有脱模剂的奥曲肽植入物 |
WO2009158412A2 (en) * | 2008-06-25 | 2009-12-30 | Endo Pharmaceuticals Solutions Inc. | Sustained delivery of exenatide and other polypeptides |
KR101820024B1 (ko) | 2008-10-17 | 2018-01-18 | 사노피-아벤티스 도이칠란트 게엠베하 | 인슐린과 glp-1 효능제의 병용물 |
JP2009149684A (ja) * | 2009-03-11 | 2009-07-09 | Amylin Pharmaceut Inc | アミリン作動薬ペプチド用製剤 |
EP2405934B1 (en) * | 2009-03-12 | 2014-03-26 | Nordic Bioscience A/S | Treatment of diabetes and metabolic syndrome |
US20110118180A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
EP3345593B1 (de) | 2009-11-13 | 2023-09-06 | Sanofi-Aventis Deutschland GmbH | Pharmazeutische zusammensetzung umfassend despro36exendin-4(1-39)-lys6-nh2 und methionin |
US20110118178A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin |
TR201809460T4 (tr) | 2009-11-13 | 2018-07-23 | Sanofi Aventis Deutschland | Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim. |
ES2606554T3 (es) | 2010-08-30 | 2017-03-24 | Sanofi-Aventis Deutschland Gmbh | Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
TWI608847B (zh) | 2011-08-29 | 2017-12-21 | 賽諾菲阿凡提斯德意志有限公司 | 用於控制糖尿病二型病患血糖的醫藥組合物 |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
BR102013017626A2 (pt) * | 2013-06-14 | 2015-02-10 | Univ Rio De Janeiro | Bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, uso de bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, composições farmacêuticas de baixa toxicidade, adjuvante para a prevenção ou tratamento das doenças, medicamento, método de tratamento ou prevenção de doenças. |
EP3189071B1 (en) * | 2014-09-04 | 2021-07-28 | Novo Nordisk A/S | Novel amylin and calcitonin receptor agonist |
PE20171622A1 (es) | 2014-12-12 | 2017-11-02 | Sanofi Aventis Deutschland | Formulacion de relacion fija de insulina glargina/lixisenatida |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
US5367052A (en) * | 1987-04-27 | 1994-11-22 | Amylin Pharmaceuticals, Inc. | Amylin peptides |
US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
US5321008A (en) * | 1991-01-10 | 1994-06-14 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
US5264372A (en) * | 1991-03-15 | 1993-11-23 | Amylin Pharmaceuticals, Inc. | Receptor-based screening methods for amylin agonists and antagonists |
US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
WO1993010146A1 (en) * | 1991-11-19 | 1993-05-27 | Amylin Pharmaceuticals, Inc. | Amylin agonist peptides and uses therefor |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
US5376638A (en) * | 1992-09-01 | 1994-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating renin-related disorders with amylin antagonists |
DE69426304T2 (de) * | 1993-09-07 | 2001-03-15 | Amylin Pharmaceuticals, Inc. | Methoden zur regulation der den magen und darm betreffenden motilitaet |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
US6087334A (en) | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
-
1995
- 1995-06-07 US US08/483,188 patent/US6143718A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 ZA ZA9604838A patent/ZA964838B/xx unknown
- 1996-06-07 WO PCT/US1996/009875 patent/WO1996040220A1/en not_active Application Discontinuation
- 1996-06-07 JP JP50206197A patent/JP4009319B2/ja not_active Expired - Fee Related
- 1996-06-07 AU AU62685/96A patent/AU721489B2/en not_active Ceased
- 1996-06-07 DK DK96921467T patent/DK0772451T3/da active
- 1996-06-07 EP EP96921467A patent/EP0772451B1/en not_active Expired - Lifetime
- 1996-06-07 CA CA2196999A patent/CA2196999C/en not_active Expired - Fee Related
- 1996-06-07 DE DE69625157T patent/DE69625157T2/de not_active Expired - Lifetime
- 1996-06-07 IN IN1053CA1996 patent/IN181672B/en unknown
- 1996-06-07 HU HU9700368A patent/HUP9700368A3/hu unknown
- 1996-06-07 CZ CZ1997337A patent/CZ289043B6/cs not_active IP Right Cessation
- 1996-06-07 AT AT96921467T patent/ATE228849T1/de active
- 1996-06-07 RU RU97104029/14A patent/RU2166958C2/ru not_active IP Right Cessation
- 1996-06-07 PT PT96921467T patent/PT772451E/pt unknown
- 1996-06-07 ES ES96921467T patent/ES2187659T3/es not_active Expired - Lifetime
- 1996-06-07 SK SK186-97A patent/SK18697A3/sk unknown
-
1997
- 1997-02-05 NO NO970519A patent/NO970519L/no unknown
- 1997-02-13 BG BG101230A patent/BG101230A/xx unknown
-
2000
- 2000-11-06 US US09/707,370 patent/US6417164B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CZ33797A3 (en) | 1997-07-16 |
ZA964838B (en) | 1997-02-24 |
JPH10503785A (ja) | 1998-04-07 |
US6143718A (en) | 2000-11-07 |
IN181672B (ru) | 1998-08-29 |
NO970519D0 (no) | 1997-02-05 |
ATE228849T1 (de) | 2002-12-15 |
EP0772451A4 (en) | 1998-09-30 |
EP0772451B1 (en) | 2002-12-04 |
DE69625157D1 (de) | 2003-01-16 |
SK18697A3 (en) | 1998-02-04 |
JP4009319B2 (ja) | 2007-11-14 |
AU721489B2 (en) | 2000-07-06 |
WO1996040220A1 (en) | 1996-12-19 |
HUP9700368A3 (en) | 2001-03-28 |
HUP9700368A2 (hu) | 1998-06-29 |
CA2196999C (en) | 2012-09-04 |
BG101230A (en) | 1997-10-31 |
RU2166958C2 (ru) | 2001-05-20 |
PT772451E (pt) | 2003-04-30 |
DK0772451T3 (da) | 2003-01-06 |
CA2196999A1 (en) | 1996-12-19 |
US6417164B1 (en) | 2002-07-09 |
HU9700368D0 (en) | 1997-04-28 |
CZ289043B6 (cs) | 2001-10-17 |
ES2187659T3 (es) | 2003-06-16 |
DE69625157T2 (de) | 2003-04-17 |
EP0772451A1 (en) | 1997-05-14 |
AU6268596A (en) | 1996-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970519L (no) | Behandling av type II diabetes mellitus med amylinagonister | |
EA199800316A1 (ru) | СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ | |
EE03202B1 (et) | Intravaginaalne manustussüsteem ja selle valmistamismeetod | |
NO20002172L (no) | FremgangsmÕte for behandling av hyperkolesterolemi med usubstituert polydiallylamin | |
GR3034508T3 (en) | Use of insulin sensitizing agents to treat hypertension. | |
EA199700119A1 (ru) | Соединения, оказывающие эффекты на системы, связанные с серотонином | |
UA29484C2 (ru) | Способ лечения миокардита, кардиомиопатии, эндокардита и перикардита | |
PT1333887E (pt) | Metodo de tratamento de desordens musculares | |
PT840601E (pt) | Thip para o tratamento de desordens do sono | |
CY1105254T1 (el) | Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο | |
EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
FI951511A (fi) | IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon | |
BR9810444A (pt) | Tratamento de diabete com rosiglitazona e insulina | |
EA200100133A1 (ru) | Оксазолидиноны для лечения инфекционных болезней глаз | |
PT888330E (pt) | Metodos de tratamento ou prevencao de cistite intersticial | |
PT869785E (pt) | 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente | |
BR9810142A (pt) | Tratamento de diabete com tiazolidinadiona e sulfonil-uréia | |
TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
SE8800461D0 (sv) | Farmaceutisk komposition | |
EA199800822A1 (ru) | Способ лечения избыточной агрессии | |
NO985325L (no) | Anvendelse av substituert azaspiran ved behandling av astma | |
EA200000418A1 (ru) | Применение тиазолидиндионов для лечения гипергликемии | |
NO950114L (no) | Amylin-antagonister og agonister | |
EA199800820A1 (ru) | Способ лечения злоупотребления лекарственными средствами | |
AU2067297A (en) | Method for treating substance abuse |